Evidence map›Paper›PMID 39347876›Full record

ArticleAnnals of nuclear medicine2025

Crossover evaluation of time-of-flight-based attenuation correction in brain

Takahiro Yamada, Kohei Hanaoka, Daisuke Morimoto-Ishikawa, Yoshiyuki Yamakawa, Shiho Kumakawa, Atsushi Ohtani, Tetsuro Mizuta, Hayato Kaida, Kazunari Ishii

Abstract readEvaluation Study
PubMed Publisher
In one paragraph

Article in Annals of nuclear medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Beyond CT: Attenuation correction for stand-alone brain PET.Zeitschrift fur medizinische Physik · 2026
    Review
  2. Off-target binding ofAnnals of nuclear medicine · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Takahiro YamadaDivision of Positron Emission Tomography Institute of Advanced Clinical Medicine, Kindai University Hospital, Osaka, Japan. h02yamada@med.kindai.ac.jp.
Kohei HanaokaDivision of Positron Emission Tomography Institute of Advanced Clinical Medicine, Kindai University Hospital, Osaka, Japan.
Daisuke Morimoto-IshikawaDivision of Positron Emission Tomography Institute of Advanced Clinical Medicine, Kindai University Hospital, Osaka, Japan.
Yoshiyuki YamakawaMedical Systems Division, Shimadzu Corporation, Kyoto, Japan.
Shiho KumakawaMedical Systems Division, Shimadzu Corporation, Kyoto, Japan.
Atsushi OhtaniMedical Systems Division, Shimadzu Corporation, Kyoto, Japan.
Tetsuro MizutaMedical Systems Division, Shimadzu Corporation, Kyoto, Japan.
Hayato KaidaDivision of Positron Emission Tomography Institute of Advanced Clinical Medicine, Kindai University Hospital, Osaka, Japan.
Kazunari IshiiDivision of Positron Emission Tomography Institute of Advanced Clinical Medicine, Kindai University Hospital, Osaka, Japan.

Funding

Advanced Research and Development Programs for Medical Innovation (AMED) JP23dk0207052
6 · The paper itself

Abstract

backgroundBrain-dedicated positron emission tomography (PET) systems offer high spatial resolution and sensitivity for accurate clinical assessments. Attenuation correction (AC) is important in PET imaging, particularly in brain studies. This study assessed the reproducibility of attenuation maps (µ-maps) generated by a specialized time-of-flight (TOF) brain-dedicated PET system for imaging using different PET tracers.

methodsTwelve subjects underwent both

resultsSmall but significant differences in µ-maps were observed between tracers, primarily in bone regions. In the comparison between the µ-maps obtained with FDG-PET and FMM-PET, the µ-maps obtained with FDG-PET had higher µ-values than those obtained with FMM-PET in the parietal regions of the head and skull, in a portion of the cerebellar dentate nucleus and on the surface of the frontal lobe. The comparison between FDG and FDG × FMM values in different regions yielded findings similar to those of the µ-maps comparison. FDG × FMM values were significantly higher than FDG values in the bilateral temporal bones and a small part of the temporal lobe. Similarly, FMM values were significantly higher than FMM × FDG values in the bilateral temporal bones. FMM × FDG values were significantly higher than FMM values in a small area of the right cerebellar hemisphere. However, the relative errors in these µ-maps were within ± 4%, suggesting that they are clinically insignificant. In PET images reconstructed with the original and swapped µ-maps, the relative errors were within ± 7% and the quality was nearly equivalent.

conclusionThese findings suggest the clinical reliability of the AC method without an external radiation source in TOF brain-dedicated PET systems.

Indexed as

Aniline CompoundsBenzothiazolesBrainFluorodeoxyglucose F18Image Processing, Computer-AssistedPositron-Emission TomographyAdultAgedFemaleHumansMaleMiddle AgedReproducibility of ResultsTime FactorsAniline CompoundsBenzothiazolesFluorodeoxyglucose F18flutemetamolAttenuation correctionBrain-dedicated PETµ-maps

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.